Literature DB >> 11277565

Increased serum S100beta protein concentrations following severe head injury in humans: a biochemical marker of brain death?

A Regner1, M Kaufman, G Friedman, I Chemale.   

Abstract

This study investigated S100beta protein as a biochemical serum marker of brain damage in severe head injury and brain death victims. Blood samples obtained from 15 patients with severe head injury admitted to the trauma intensive care unit (ICU), five patients with a diagnosis of brain death due to hemorrhage following cerebral aneurysm rupture, and five healthy individuals were investigated. The S100beta protein serum concentrations were analyzed with a immunoradiometric assay kit. The 15 patients with severe head injury were followed up for 6 months. Outcome was considered either death or recovery with ICU discharge. S100beta concentrations were closely related to brain damage. Among the severe head injury victims, higher S100beta concentrations were detected in those patients that progressed to death. The individuals with brain death had similar mean S100beta concentrations, irrespective of its cause (either trauma or vascular rupture). S100beta protein is a promising serum outcome predictor for severe head injury victims and may contribute to the early diagnosis of brain death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277565     DOI: 10.1097/00001756-200103260-00015

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Predictive biomarkers of recovery in traumatic brain injury.

Authors:  Sabrina Giacoppo; Placido Bramanti; Marina Barresi; Debora Celi; Valeria Foti Cuzzola; Eleonora Palella; Silvia Marino
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.

Authors:  T Himeda; Y Watanabe; H Tounai; N Hayakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

3.  Pitfalls in the diagnosis of brain death.

Authors:  Katharina M Busl; David M Greer
Journal:  Neurocrit Care       Date:  2009-05-15       Impact factor: 3.210

4.  S100B protein may detect brain death development after severe traumatic brain injury.

Authors:  Juan J Egea-Guerrero; Francisco Murillo-Cabezas; Elena Gordillo-Escobar; Ana Rodríguez-Rodríguez; Judy Enamorado-Enamorado; Jaume Revuelto-Rey; María Pacheco-Sánchez; Antonio León-Justel; Jose M Domínguez-Roldán; Angel Vilches-Arenas
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

5.  HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?

Authors:  Andrea Regner; Ottomar Bianchini; Claudio Jardim; Marcio Menna-Barreto
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

6.  Effects of chronic administration with nilvadipine against immunohistochemical changes related to aging in the mouse hippocampus.

Authors:  Toshiki Himeda; Shiori Kanbara; Chie Oki; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

7.  Mood disorders are glial disorders: evidence from in vivo studies.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Julia Sacher; Johann Steiner; Ingolf E Blasig; Karsten Mueller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-05-27

8.  Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.

Authors:  Yu Watanabe; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2007-11-21       Impact factor: 3.584

9.  Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury.

Authors:  Edison Moraes Rodrigues Filho; Daniel Simon; Nilo Ikuta; Caroline Klovan; Fernando Augusto Dannebrock; Carla Oliveira de Oliveira; Andrea Regner
Journal:  J Neurotrauma       Date:  2014-08-04       Impact factor: 5.269

Review 10.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.